He ruled the operating room and then daytime TV. Now, Dr. Oz is set to take over a $1.5 trillion health agency.
 David Dermer/AP
He ruled the operating room and then daytime TV. Now, Dr. Oz is set to take over a $1.5 trillion health agency Dr. Oz has kept a decidedly low profile since his nomination, and he hasn't given any clues about his plans for the agency he'll likely run. What is clear: Like most Republicans, he's all in on privatized Medicare — he once called for Medicare Advantage for All, which is exactly what it sounds like. And he seems willing to amend his views so they fall in line with his party, even if that means pushing back against Covid-19 lockdowns, for example. Read more. By Tara Bannow |
|
 Photo illustration: Christine Kao/STAT; Photos: Adobe
The CRISPR companies are not OK Interviews with over 75 investors, academics, executives, analysts, and employees reveal a swaggering industry suddenly and deeply humbled. Put simply, they've realized — billions of dollars and more than a few ill-conceived companies later — that there are surprisingly few places today where you can both cure a disease with gene editing and make money. Read more. By Jason Mast
 José A. Alvarado Jr. for STAT
What happens when a rare disease drug seems to work, but the health care system doesn't? Cristina Brennan can hear the clock ticking. At the end of the year, her 12-year-old son Tristan will no longer have free access to a pricey medicine that has successfully helped him combat a rare form of epilepsy. This means that after being on the treatment — made available to him through a clinical trial since early 2022 — he may once again have to cope with seizures that will worsen his health, diminish his quality of life, and place a proverbial cloud over his future. Read more. By Ed Silverman
In case you missed it |
|
Check out more exclusive coverage with a STAT+ subscription | Read premium in-depth biotech, pharma, policy, and life science coverage and analysis with all of our STAT+ articles. |
|
| STAT, 1 Exchange Place, Boston, MA | ©2025, All Rights Reserved. | |
|
No comments